Drug intelligence / Profile preview

K-285

Development stage: Unknown
Lead developer: Kowa Research Institute
Modality: Hydrogel Systems → Drug Delivery Systems, Small Molecules
Administration: Topical

Overview

K-285 is an investigational topical gel developed for the treatment of delayed onset muscle soreness (DOMS). It has been evaluated in phase II clinical trials, where its efficacy and safety were compared to menthol gel in subjects experiencing DOMS induced by exercise. The studies involved randomized, double-blind, active comparator designs with endpoints focused on pain reduction and safety assessments. The mechanism of action is not explicitly stated in available sources; however, it is being studied as a topical analgesic for musculoskeletal pain relief.

Beyond the preview

Go deeper on K-285.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on K-285.

Explore the full profile